Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-08 @ 9:28 AM
Study NCT ID:
NCT02439957
Status:
TERMINATED
Last Update Posted:
2021-07-16
First Post:
2015-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
Sponsor:
Jazz Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CMX001-307
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None